Evidence map›Paper›PMID 42789544›Full record

ArticlePloS one2026

Pathways to health resilience: A cross-country analysis of health system response to re-emerging infectious diseases in Sub-Saharan Africa.

Stephen T Odonkor

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Stephen T OdonkorSchool of Public Service and Governance, Ghana Institute of Management and Public Administration, Accra, Ghana.ORCID https://orcid.org/0000-0002-8149-9936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sub-Saharan Africa (SSA) faces recurrent threats from re-emerging infectious diseases, including Ebola virus disease, cholera, measles, Lassa fever, and Marburg virus disease. This study assessed the resilience of health systems in 25 SSA countries from 2000 to 2023 using a multidimensional resilience index and a first-order Markov state-transition framework. Country-year observations were classified as Low Resilience, Moderate Resilience, or High Resilience based on epidemiological performance, health financing, surveillance, response capacity, and recovery indicators. Resilience was heterogeneous and path-dependent. Low-Resilience observations had an 82.4% probability of remaining in that state in the subsequent year and only a 3.1% probability of moving directly to High Resilience. Moderate-Resilience observations had a 19.1% probability of transitioning to High Resilience and an 18.2% probability of declining to Low Resilience. High-Resilience observations had a 63.6% probability of remaining High Resilience, but a combined 36.4% probability of regression. Multinomial logistic regression showed that health expenditure per capita, domestic health-financing share, and GDP per capita were positively associated with High Resilience, whereas internal armed conflict was negatively associated with High Resilience. Southern and Eastern Africa showed stronger resilience profiles than Western and Central Africa, while Central Africa had the greatest concentration of Low-Resilience countries. These findings indicate that resilience is dynamic, unevenly distributed, and strongly shaped by sustained financing, economic capacity, and political stability. Policy priorities include strengthening domestic health financing, targeting Moderate-Resilience countries for accelerated improvement, supporting conflict-affected systems, and harmonising regional surveillance and emergency-response mechanisms.

Indexed as

Communicable Diseases, EmergingDelivery of Health CareAfrica South of the SaharaHumans

Identifiers

PMID42789544
PMCPMC13614545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.